ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...
Transforming US drug access and production: MFN pricing deals and historic manufacturing investments
In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the ...
In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug ...
The Chosun Ilbo on MSN
Pharmaceutical industry demands drug price policy reconsideration
The pharmaceutical and biotech industry could suffer annual losses of up to 3.6 trillion won if a policy cutting generic drug ...
Pharmaceutical Technology on MSN
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus
The approval marks the first new pharmacologic treatment in motion sickness in over four decades. The US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback